BlackRock’s Amgen AMGN Stock Holding History

BlackRock’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-600	Closed	-$100K	–	3728
2016 Q3	$100K	Buy	+600	New	+$101K	﹤0.01%	2590

Other funds holding AMGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock's AMGN Position: Q1 2026 in Review

BlackRock reduced its Amgen (AMGN) stake by 0.62% in Q1 2026, selling an estimated $105M and leaving 47,100,472 shares worth $16.6B. The position accounts for 0.29% of the portfolio, ranked #55.

BlackRock first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

BlackRock held 47,100,472 shares of Amgen worth $16.6B as of Q1 2026.
BlackRock sold 295,666 Amgen shares in Q1 2026, an estimated $105M.
Amgen made up 0.29% of BlackRock's portfolio in Q1 2026, its #55 holding.
BlackRock first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.